HRCT Imaging of Airway Responsiveness: Effects of Anesthetics

  • Robert H. Brown
Article

Abstract

The noninvasive imaging method, high resolution computed tomography (HRCT), has been developed in animal models and applied to humans with obstructive lung disease for assessing regional and individual airway responsiveness. The ability to directly view airway responses during provocations such as tracheal intubation in an asthmatic could greatly enhance our understanding and treatment of airway hyperresponsiveness. HRCT uses increased kilovoltage peak (kVp) and milliamperage (mAs) settings, thin slices, high spacial frequency reconstruction algorithms, and small fields of view to resolve structures as small as 200 µm. Therefore, airways as small as 1–2 mm in diameter can be viewed and measured. HRCT is a more sensitive technique for resolving airway caliber changes than clinical or research methods of pulmonary function tests. HRCT allows direct in vivo measurement of airway responsiveness to pharmacological and physiological stress that induces bronchoconstriction or bronchodilation. Using HRCT, we are able to measure airway dilation at baseline airway tone with inhalation anesthetics, differentiate the bronchodilating properties of inhalational agents in airways with tone, assess bronchodilating agents commonly used as premedications prior to anesthesia, and measure airway heterogeneity at baseline tone and their response to a variety of stimuli. This ability of HRCT to measure airway caliber and response heterogeneity in vivo noninvasively will dramatically improve our understanding of pulmonary physiology in general and the effects of anesthetics on the airways specifically.

airways anesthetics bronchoconstriction bronchodilation high resolution computed tomography muscarinic 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    King GG, Eberl S, Salome CM, Meikle SM, Woolcock AJ. Airway closure measured by technegas bolus and SPECT. AmJ Respir Crit CareMed 1997; 155: 682–688Google Scholar
  2. 2.
    Naidich DP, Zerhouni EA, Siegelman SS. Computed Tomography of the Thorax. New York: Raven Press, 1984Google Scholar
  3. 3.
    Zerhouni EA, Naidich DP, Stitik FP, Khouri NF, Siegelman SS. Computed tomography of the pulmonary paren-chyma II: Interstitial disease. J Thorac Imaging 1985; 1: 54–64PubMedGoogle Scholar
  4. 4.
    Mayo JR, Webb WR, Gould R, Stein MG, Bass I, Gamsu G, Goldberg HI. High-resolution CT of the lungs: An optimal approach. Radiology 1987; 163: 507–510PubMedGoogle Scholar
  5. 5.
    Murata K, Kahn A, Rojas KA, Herman PG. Optimization of computed tomography technique to demonstrate the fine structure of the lung. Invest Radiol 1988; 23: 170–175PubMedGoogle Scholar
  6. 6.
    Amirav I, Kramer SS, Grunstein MM, Hoffman EA. Assessment of methacholine-induced airway constriction by ultrafast high-resolution computed tomography. J Appl Physiol 1993; 75: 2239–2250PubMedGoogle Scholar
  7. 7.
    Brown RH, Mitzner W. Effect of lung inflation and airway muscle tone on airway diameter in vivo. J Appl Physiol 1996; 80: 1581–1588PubMedGoogle Scholar
  8. 8.
    Herold CJ, Brown RH, Mitzner W, Links JM, Hirshman CA, Zerhouni EA. Assessment of pulmonary airway reactivity with high-resolution CT. Radiology 1991; 181: 369–374PubMedGoogle Scholar
  9. 9.
    Brown RH, Zerhouni EA, Mitzner W. Airway edema potentiates airway reactivity. J Appl Physiol 1995; 79: 1242–1248PubMedGoogle Scholar
  10. 10.
    Wood SA, Zerhouni EA, Hoford JD, Hoffman EA, Mitzner W. Measurement of three-dimensional lung tree structures by using computed tomography. J Appl Physiol 1995; 79: 1687–1697PubMedGoogle Scholar
  11. 11.
    Brown RH, Herold CJ, Hirshman CA, Zerhouni EA, Mitzner W. In vivo measurements of airway reactivity using high-resolution computed tomography. Am Rev Respir Dis 1991; 144: 208–212PubMedGoogle Scholar
  12. 12.
    Boulet LP, Belanger M, Carrier G. Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airway flow obstruction. Am J Respir Crit Care Med 1995; 152: 865–871PubMedGoogle Scholar
  13. 13.
    Okazawa M, Muller N, McNamara AE, Child S, Verburgt L, Pare PD. Human airway narrowing measured using high resolution computed tomography. Am J Respir Crit CareMed 1996; 154: 1557–1562Google Scholar
  14. 14.
    Choi BW, Lee SP, Park IW, Kim YS, Kim YG, Hue SH, Kim KS. The airway response to bronchodilator using high resolution computed tomography in patients with bronchial asthma. Am J Respir Crit Care Med 1994; 149: A203 (Abstract)Google Scholar
  15. 15.
    Brown RH, Diemer F, Mudge B, Permutt S, Togias A. Mechanisms underlying the inability of lung inflation to relax asthmatic airways. Anesth Analg 1999; 88: A410 (Abstract)CrossRefGoogle Scholar
  16. 16.
    Brown RH, Mitzner W, Zerhouni E, Hirshman CA. Direct in vivo visualization of bronchodilation induced by inhalational anesthesia using high resolution computed tomography (HRCT). Anesthesiol 1993; 78: 295–300Google Scholar
  17. 17.
    Brown RH, Zerhouni EA, Hirshman CA. Comparison of low concentrations of halothane and isoflurane as bronchodilators. Anesthesiol 1993; 78: 1097–1101Google Scholar
  18. 18.
    Brown RH, Herold CJ, Hirshman CA, Zerhouni EA, Mitzner W. Individual airway constrictor response hetero-geneity assessed by high resolution computed tomography. J Appl Physiol 1993; 74: 2615–2620PubMedGoogle Scholar
  19. 19.
    Brown RH, Herold C, Mitzner W, Zerhouni EA. Spontaneous airways constrict during breath holding studied by high-resolution computed tomography. Chest 1994; 106: 920–924PubMedGoogle Scholar
  20. 20.
    Brown RH, Zerhouni EA, Hirshman CA. Reversal of bronchoconstriction by inhaled nitric oxide: Histamine versus methacholine. Am J Respir Crit Care Med 1994; 150: 233–237PubMedGoogle Scholar
  21. 21.
    Brown RH, Zerhouni EA, Mitzner W. Visualization of airway obstruction in vivo during lung vascular engorgement and edema. J Appl Physiol 1995; 78: 1070–1078PubMedGoogle Scholar
  22. 22.
    Brown RH, Robbins W, Staats P, Hirshman CA. Prevention of bronchoconstriction by an orally active local anesthetic. Am J Respir Crit Care Med 1995; 151: 1239–1243PubMedGoogle Scholar
  23. 23.
    Brown RH, Zerhouni EA, Mitzner W. Variability in the size of individual airways over the course of one year. AmJ Respir Crit CareMed 1995; 151: 1159–1164Google Scholar
  24. 24.
    Brown RH, Mitzner W, Bulut Y, Wagner EM. Effects of lung inflation in vivo on airways with smooth muscle tone or edema. J Appl Physiol 1997; 82: 491–499PubMedCrossRefGoogle Scholar
  25. 25.
    Groeben H, Brown RH. Ipratropium decreases airway size by preferential M2 muscarinic receptor blockade. Anesthesiol 1996; 85: 867–873CrossRefGoogle Scholar
  26. 26.
    Herold CJ, Wetzel RC, Robotham JL, Herold SM, Zerhouni EA. Acute effects of increased intravascular volume and hypoxia on the pulmonary circulation: Assessment with high-resolution CT. Radiology 1992; 183: 655–662PubMedGoogle Scholar
  27. 27.
    Wetzel RC, Herold CJ, Zerhouni EA, Robotham JL. Hypoxic bronchodilation. J Appl Physiol 1992; 73: 1202–1206PubMedGoogle Scholar
  28. 28.
    McNamara AE, Muller NL, Okazawa M, Arntorp J, Wiggs BR, Pare PD. Airway narrowing in excised canine lungs measured by high-resolution computed tomography. J Appl Physiol 1992; 73: 307–316PubMedGoogle Scholar
  29. 29.
    Forster BB, Muller NL, Mayo JR, Okazawa M, Wiggs BJR, Pare PD. High-resolution computed tomography of experimental hydrostatic pulmonary edema. Chest 1992; 101: 434–437Google Scholar
  30. 30.
    Paganin F, Vignola AM, Seneterre E, Bruel JM, Chanez P, Bousquet J. Heterogeneity of airways obstruction in asthmatic patients using high resolution computed tomography. Chest 1995; 107: 145S-146SPubMedGoogle Scholar
  31. 31.
    Hughes JMB, Hoppin FG Jr, Mead J. Effect of lung inflation on bronchial length and diameter in excised lungs. J Appl Physiol 1972; 32: 25–35PubMedGoogle Scholar
  32. 32.
    Murtagh PS, Proctor DF, Permutt S, Kelly B, Evering S. Bronchial closure with Mecholyl in excised dog lobes. J Appl Physiol 1971; 31: 409–415PubMedGoogle Scholar
  33. 33.
    Hyatt RE, Flath RE. Influence of lung parenchyma on pressure-diameter behavior of dog bronchi. J Appl Physiol 1966; 21: 1448–1452PubMedGoogle Scholar
  34. 34.
    Rozas CJ, Goldman AL. Daily spirometric variability: Normal subjects and subjects with chronic bronchitis with and without airflow obstruction. Arch Intern Med 1982; 142: 1287–1291PubMedCrossRefGoogle Scholar
  35. 35.
    Nickerson BG, Lemen RJ, Gerdes CB, Wegmann MJ, Robertson G. Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis 1980; 122: 859–866PubMedGoogle Scholar
  36. 36.
    Dawson A. Reproducibility of spirometric measurements in normal subjects. Am Rev Respir Dis 1966; 93: 264–269PubMedGoogle Scholar
  37. 37.
    American Thoracic Society. Lung function testing: Selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202–1218Google Scholar
  38. 38.
    Hickey RF, Graf PD, Nadel JA, Larson CP. The effects of halothane and cyclopropane on total pulmonary resistance in the dog. Anesthesiol 1969; 31: 334–343Google Scholar
  39. 39.
    Hirshman CA, Bergman NA. Factors influencing intra-pulmonary airway calibre during anaesthesia. Br J Anaesth 1990; 65: 30–42PubMedGoogle Scholar
  40. 40.
    Hirshman CA, Edelstein G, Peetz S, Wayne R, Downes H. Mechanism of action of inhalational anesthesia on airways. Anesthesiol 1982; 56: 107–111Google Scholar
  41. 41.
    Warner DO, Vettermann J, Brichant J-F, Rehder K. Direct and neurally mediated effects of halothane on pulmonary resistance in vivo. Anesthesiol 1990; 72: 1057–1063Google Scholar
  42. 42.
    Vettermann J, Beck KC, Lindahl SHE, Brichant JF, Rehder K. Actions of enflurane, isoflurane, vecuronium, atracurium and pancuronium on pulmonary resistance in dogs. Anesthesiol 1988; 69: 688–695Google Scholar
  43. 43.
    Alexander CM, Chen L, Ray R, Marshall BE. The influence of halothane and isoflurane on pulmonary collateral ventilation. Anesthesiol 1985; 62: 135–140CrossRefGoogle Scholar
  44. 44.
    Nishino T, Tanaka A, Ishikawa T, Hiraga K. Respiratory, laryngeal, and tracheal responses to nasal insufflation of volatile anesthetics in anesthetized humans. Anesthesiol 1991; 75: 441–444Google Scholar
  45. 45.
    Dixon M, Jackson DM, Richards IM. The effects of histamine, acetylcholine and 5-hydroxytryptamine on lung mechanics and irritant receptors in the dog. J Physiol (Lond) 1979; 287: 393–403PubMedGoogle Scholar
  46. 46.
    Richardson JB. Nerve supply to the lungs. Am Rev Respir Dis 1979; 119: 785–802PubMedGoogle Scholar
  47. 47.
    Weiss ER, Anderson WH, O'Brien KP. The effect of a local anesthetic, lidocaine, on guinea pig trachealis muscle in vitro. Am Rev Respir Dis 1975; 112: 393–400PubMedGoogle Scholar
  48. 48.
    Downes H, Loehning RW. Local anesthetic contracture and relaxation of airway smooth muscle. Anesthesiol 1977; 47: 430–436Google Scholar
  49. 49.
    Scott DB, Littlewood DG, Covino BG, Drummond GB. Plasma lignocaine concentrations following endotracheal spraying with an aerosol. Br J Anaesth 1976; 48: 899–902PubMedGoogle Scholar
  50. 50.
    Miller WC, Awe R. Effect of nebulized lidocaine on reactive airways. Am Rev Respir Dis 1975; 111: 739–741PubMedGoogle Scholar
  51. 51.
    Weiss EB, Patwardhan AV. The response to lidocaine in bronchial asthma. Chest 1977; 72: 429–438PubMedGoogle Scholar
  52. 52.
    Fish JE, Peterman VI. Effects of inhaled lidocaine on airway function in asthmatic subjects. Respiration 1979; 37: 201–207PubMedCrossRefGoogle Scholar
  53. 53.
    Downes H, Hirshman CA. Importance of calcium in citric acid-induced airway constriction. J Appl Physiol 1983; 55: 1496–1500PubMedGoogle Scholar
  54. 54.
    Downes H, Hirshman CA. Calcium chelators increase airway responsiveness. J Appl Physiol 1985; 59: 92–95PubMedGoogle Scholar
  55. 55.
    Downes H, Hirshman CA. Lidocaine aerosols do not prevent allergic bronchoconstriction. Anesth Analg 1981; 60: 28–32PubMedGoogle Scholar
  56. 56.
    Steinhaus JE, Gaskin L. A study of intravenous lidocaine as a suppressant of cough reflex. Anesthesiology 1963; 24: 285–290PubMedGoogle Scholar
  57. 57.
    Steinhaus JE, Howland DE. Intravenously administered lidocaine as a supplement to nitrous oxide-thiobarbiturate anesthesia. Anesth Analg 1958; 37: 40–46PubMedGoogle Scholar
  58. 58.
    Gonzalez RM, Bjerke RJ, Drobycki T, Stapelfeldt WH, Green JM, Janowitz MJ, Clark M. Prevention of endo-tracheal tube-induced coughing during emergence from general anesthesia. Anesth Analg 1994; 79: 792–795PubMedGoogle Scholar
  59. 59.
    Gewalt SL, Glover GH, Hedlund LW, Cofer GP, MacFall JR, Johnson GA. MR microscopy of the rat lung using projection reconstruction. Magn Reson Med 1993; 29: 99–106PubMedGoogle Scholar
  60. 60.
    Nishino T, Hiraga K, Sugimori K. Effects of i.v. lignocaine on airway reflexes elicited by irritation of the tracheal mucosa in humans anaesthetized with enflurane. Br J Anaesth 1990; 64: 682–687PubMedGoogle Scholar
  61. 61.
    Bulut Y, Hirshman CA, Brown RH. Prevention of lidocaine aerosol-induced bronchoconstriction with intravenous lidocaine. Anesthesiol 1996; 85: 853–859CrossRefGoogle Scholar
  62. 62.
    Groeben H, Foster WM, Brown RH. Intravenous lidocaine and oral mexiletine block reflex bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1996; 154: 885–888PubMedGoogle Scholar
  63. 63.
    Shnider SM, Papper EM. Anesthesia for the asthmatic patient. Anesthesiol 1961; 22: 886–892Google Scholar
  64. 64.
    Kil HK, Rooke GA, Ryan-Dykes MA, Bishop MJ. Effect of prophylactic bronchodilator treatment on lung resistance after tracheal intubation. Anesthesiol 1994; 81: 43–48Google Scholar
  65. 65.
    Gold WM, Kessler G-F, Yu DYC. Role of vagus nerves in experimental asthma in allergic dogs. J Appl Physiol 1972; 33: 719–725PubMedGoogle Scholar
  66. 66.
    Nadel JA, Cabezas GA, Austin JHM. In vivo roentgenographic examination of parasympathetic innervation of small airways. Invest Radiol 1971; 6: 9–17PubMedGoogle Scholar
  67. 67.
    Dixon M, Jackson DM, Richards IM. A study of the afferent and efferent nerve distribution to the lungs of dogs. Respiration 1980; 39: 144–149PubMedGoogle Scholar
  68. 68.
    Roffel AF, Elzinga CRS, Zaagsma J. Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990; 3: 47–51PubMedCrossRefGoogle Scholar
  69. 69.
    Widdicombe JG. Regulation of tracheobronchial smooth muscle. Physiol Rev 1963; 43: 1–37PubMedGoogle Scholar
  70. 70.
    Fryer AD, Maclagan J. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea pig. Br J Pharmacol 1984; 83: 973–978PubMedGoogle Scholar
  71. 71.
    Baker DG, Don HF, Brown JK. Direct measurement of acetylcholine release in guinea pig trachea. Am J Physiol (Lung CellMol Physiol) 1992; 263: L142-L147Google Scholar
  72. 72.
    Patel HJ, Barnes PJ, Takahashi T, Tadjkarimi S, Yacoub MH, Belvisi MG. Evidence for prejunctional muscarinic autoreceptors in human and guinea pig trachea. Am J Respir Crit Care Med 1995; 152: 872–878PubMedGoogle Scholar
  73. 73.
    Fryer AD, Maclagan J. Ipratropium bromide potentiates bronchoconstriction by vagal nerve stimulation in the guinea-pig. Eur J Pharmacol 1987; 139: 187–191PubMedCrossRefGoogle Scholar
  74. 74.
    Connolly CK. Adverse reaction to ipratropium bromide. BMJ 1982; 285: 934–935PubMedGoogle Scholar
  75. 75.
    Patel KR, Tullett WM. Bronchoconstriction in response to ipratropium bromide. BMJ 1983; 286: 1318PubMedGoogle Scholar
  76. 76.
    Mann JS, Howarth PH, Holgate ST. Bronchoconstriction induced by ipratropium bromide in asthma: Relation to hypotonicity. BMJ 1984; 289: 469PubMedGoogle Scholar
  77. 77.
    Rafferty P, Beasley R, Holgate ST. Comparison of preservative-free ipratropium bromide and atrovent nebuliser solution. Thorax 1988; 43: 446–450PubMedCrossRefGoogle Scholar
  78. 78.
    Rafferty P, Beasley R, Howarth PH, Mann JS, Holgate ST. Bronchoconstriction induced by nebulised ipratropium bromide: Relation to bromide ion. BMJ 1986; 293: 1538–1539PubMedGoogle Scholar
  79. 79.
    O'Callaghan C, Milner AD, Swarbrick A. Paradoxical bronchoconstriction in wheezing infants after nebulised preservative free iso-osmolar ipratropium bromide. BMJ 1989; 299: 1433–1434PubMedCrossRefGoogle Scholar
  80. 80.
    Disse B, Reichl R, Speck G, Traunecker W, Rominger KL, Hammer R. Ba 679 BR, a novel long-acting anticholinergic bronchodilator. Life Sci 1993; 52: 537–544PubMedCrossRefGoogle Scholar
  81. 81.
    Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci 1993; 52: 521–527PubMedCrossRefGoogle Scholar
  82. 82.
    Ingram RH, Welman JJ, McFadden ER, Mead J. Relative contributions of large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol. J Clin Invest 1977; 59: 696–703PubMedCrossRefGoogle Scholar
  83. 83.
    Macklem PT, Woolcock AJ, Hogg JC, Nadel JA, Wilson NJ. Partitioning of pulmonary resistance in the dog. J Appl Physiol 1969; 26: 798–805PubMedGoogle Scholar
  84. 84.
    Michel AD, Delmendo RE, Lopez M, Whiting RL. On the interaction of gallamine with muscarinic receptor subtypes. Eur J Pharmacol 1990; 182: 335–345PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • Robert H. Brown
    • 1
  1. 1.Department of Anesthesiology and Critical Care Medicine, Environmental Health Sciences/Division of Physiology, and RadiologyJohns Hopkins UniversityBaltimoreU.S.A.

Personalised recommendations